Exacerbation of protracted-relapsing experimental allergic encephalomyelitis in DA rats by gluten-free diet

APMIS

Volumn 112, Issue 10, 2004, Pages 651-5

  Di Marco, Roberto ^a   Mangano, Katia ^a   Quattrocchi, Cinzia ^a   Amato, Filiberto ^a   Nicoletti, Ferdinando ^a,c   Buschard, Karsten ^b  

^a UNIVERSITY OF CATANIA   (Italy)

^b Kommunehospitalet ^*  (Denmark)

^c Department of Biomedical Sciences ^*  (Italy)

Author keywords

Celiac disease; DA rats; EAE; Experimental allergic encephalomyelitis; Gluten free diet; MS; Multiple sclerosis; Paresis; Type 1 diabetes mellitus

Indexed keywords

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE EXACERBATION; GLUTEN FREE DIET; MALE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; RAT; RECURRENT DISEASE; TREATMENT FAILURE;

EID: 11944258343     PISSN: 09034641     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2004.apm1121003.x     Document Type: Article

References (19)

1. Parish NM, Hutchings PR, O'Reilly L, Quartey-Papafio L, Healey D, Ozegbe P, Cooke A. Tolerance induction as a therapeutic strategy for the control of autoimmune endocrine disease in mouse models. Immunol Rev 1995;144:269-300.
2. Hunt BS. Diet and multiple sclerosis. Lancet 1974;2:1512.
3. Scott FW, Marliss EB. Conference summary: diet as an environmental factor in development of insulin-dependent diabetes mellitus. Can J Physiol Pharmacol 1990;69:311-9.
4. Barbeau WE. Interactions between dietary proteins and the human system: implications for oral tolerance and food-related diseases. Adv Exp Med Biol 1997;415:183-93.
5. Ghezzi A, Zafferoni M. Neurological manifestations of gastrointestinal disorders with particular reference to the differential diagnosis of multiple sclerosis. Neurol Sci (Suppl) 2001;2:S117-22.
6. Hunter AL, Rees BW, Jones LT. Gluten antibodies in patients with multiple sclerosis. Hum Nutr Appl Nutr 1984;38:142-3.
7. Hadjivassiliou M, Gibson A, Davies-Jones GA, Lobo AJ, Stephenson TJ, Milford-Ward A. Does cryptic gluten sensitivity play a part in neurological illness? Lancet 1996;347:369-71.
8. Bateson MC, Hopwood D, MacGillivray JB. Jejunal morphology in multiple sclerosis. Lancet 1979;26:1108-10.
9. Hafner FH. Gluten-free diet as treatment for multiple sclerosis. Postgrad Med 1976;59:20.
10. Hawson DC. Is there a role for gluten-free diets in multiple sclerosis? Hum Nutr Appl Nutr 1984;38:417-20.
11. Lorentzen JC, Issazadeh S, Storch M, Mustafa MI, Lassman H, Linington C, Klareskog L, Olsson T. Protracted, relapsing and demyelinating experimental autoimmune encephalomyelitis in DA rats immunized with syngenic spinal cord and incomplete Freund's adjuvant. J Neuroimmunol 1995;63:193-205.
12. Di Marco R, Khademi M, Wallstrom E, Iacobeus E, Salvaggio A, Caracappa S, Papoian R, Nicoletti F, Olsson T. Curative effects of recombinant human interleukin-6 in DA rats with protracted relapsing experimental allergic encephalomyelitis. J Neuroimmunol 2001;116:168-77.
13. Funda DP, Kaas A, Bock T, Tlaskalová-Hogenová, Buschard K. Gluten-free diet prevents diabetes in NOD mice. Diabetes Metab Res Rev 1999;15:323-7.
14. Bach JF. Insulin-dependent diabetes mellitus as an autoimmune disease. Endocr Rev 1994;15:516-42.
15. Hunter SF, Rodriguez M. Multiple sclerosis: a unique immunopathological syndrome of the central nervous system. Springer Semin Immunopathol 1995;17:89-105.
16. Wucherpfenning KW. Insights into autoimmunity gained from structural analysis of MHC-peptide complexes. Curr Opin Immunol 2001;13:650-6.
17. Hoorfar J, Buschard K, Dagnaes-Hansen F. Prophylactic nutritional modification of the incidence of diabetes in autoimmune non-obese diabetic (NOD) mice. Br J Nutr 1993;69:597-607.
18. Pastore MR, Bazzigaluppi E, Belloni C, Arcovio C, Bonifacio E, Bosi E. Six months of gluten-free diet do not influence autoantibody titers, but improve insulin secretion in subjects at high risk for type 1 diabetes. J Clin Endocrinol Metab 2003;88:162-5.
19. Prud'homme GJ. Gene therapy of autoimmune diseases with vectors encoding regulatory cytokines or inflammatory cytokine inhibitors. J Gene Med 2000;2:222-32.